Key Takeaways -
• President Trump’s administration is actively reviewing a proposal to move cannabis from Schedule I to Schedule III of the federal Controlled Substances Act (CSA) and a decision on rescheduling is expected...more
8/21/2025
/ Banking Sector ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances Act ,
Department of Justice (DOJ) ,
Food and Drug Administration (FDA) ,
IRS ,
Marijuana ,
Medical Marijuana ,
Popular ,
Regulatory Reform ,
Research and Development ,
Schedule I Drugs ,
Tax Planning ,
Trump Administration